IMAX Corporation
In the published model solve dated 2026-Q2, anchored at $47.36, IMAX Corporation (IMAX) is priced for today's economics sustained for ~6.7 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
• IMAX licenses its premium large-format projection systems and image technology to cinemas worldwide and takes a cut of the box office, operating a network of 1,864 systems across 91 countries rather than owning theaters [Source: IMAX FY2025 results, 10-K]. • The risk is the price extrapolating a record year: at about 36 times operating income the market is paying for growth at the company's self-funding ceiling to hold for roughly seven years, while box office is inherently hit-driven and lump
Is IMAX overvalued? See what's priced in →
245 institutional managers reported holding IMAX in 13F filings for the quarter ended 2026-03-31. Together they hold about 84% of the company; the top 10 hold 43%. 47 opened new positions that quarter. Held by FMR (Fidelity), BlackRock, Royce & Associates, among others. On the short side, 6.2M shares were sold short as of the 2026-06-15 count, about 11% of shares outstanding (7.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
IMAX has cut its share count 5% over the past five years, spending $89.85M on repurchases. It pays no dividend. Cash returned over the past three years: $18.35M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at IMAX over the trailing three years. Absence is a fact about the company, not a signal. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
IMAX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-27 | +11.5% | +0.9% |
| 2023-10-26 | -0.3% | -17.9% |
| 2024-02-28 | +12.0% | -7.7% |
| 2024-04-26 | -2.9% | -2.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
IMAX's latest 8-K filings: 2026-07-23 (items 2.02, 9.01); 2026-06-11 (items 5.07); 2026-04-30 (items 2.02, 9.01); 2026-04-17 (items 5.02); 2026-03-30 (items 7.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.